Our findings demonstrate the role of MNX1 in upregulating Pbxip1, Pbx1, and Pbx4, highlighting their possible contributions to MNX1-induced epigenetic alterations, and positioning them as potential therapeutic targets for t(7;12) AML. This evidence concerns the gene PBXIP1 and acute myeloid leukemia.